Synthesis, In Vitro Biological Evaluation and Molecular Modeling of Benzimidazole-Based Pyrrole/Piperidine Hybrids Derivatives as Potential Anti-Alzheimer Agents
暂无分享,去创建一个
W. Rehman | F. Rahim | M. A. Bhat | H. Ullah | Misbah Ullah Khan | M. Sarfraz | Shoaib Khan | Rafaqat Hussain | Naveed Iqbal | Syed Adnan Ali Shah | Sundas Tariq | Amjad Hussain | Muhammad Kamran Farooqi
[1] F. Rahim,et al. Design, Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Study of Benzimidazole-Based Oxazole Analogues: A Promising Acetylcholinesterase and Butyrylcholinesterase Inhibitors , 2023, Molecules.
[2] M. Marinescu. Benzimidazole-Triazole Hybrids as Antimicrobial and Antiviral Agents: A Systematic Review , 2023, Antibiotics.
[3] R. Hussain,et al. Synthesis, in Vitro Bio-evaluation, and Molecular Docking Study of Thiosemicarbazone-based Isatin/bis-Schiff base Hybrid Analogues as Effective Cholinesterase Inhibitors , 2023, Journal of Molecular Structure.
[4] R. Hussain,et al. Synthesis, DFT Studies, Molecular Docking and Biological Activity Evaluation of Thiazole-Sulfonamide Derivatives as Potent Alzheimer’s Inhibitors , 2023, Molecules.
[5] R. Hussain,et al. Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer’s Disease Candidates: Evidence-Based In Vitro Study , 2022, Molecules.
[6] I. Ullah,et al. Synthesis, biological evaluation and molecular docking study of benzimidazole derivatives as α-glucosidase inhibitors and anti-diabetes candidates , 2022, Journal of Molecular Structure.
[7] M. Ghate,et al. Synthesis, Antioxidant and Anti-diabetic potential of novel benzimidazole substituted coumarin-3-carboxamides , 2022, Journal of Molecular Structure.
[8] R. Hussain,et al. Synthesis, in vitro α-amylase, α-glucosidase activities and molecular docking study of new benzimidazole bearing thiazolidinone derivatives , 2022, Journal of Molecular Structure.
[9] S. Mandal,et al. Synthesis, Characterization and Biological Evaluation of Benzimidazole and Benzindazole Derivatives as Anti-hypertensive Agents , 2021 .
[10] Na Ye,et al. Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases. , 2020, Journal of medicinal chemistry.
[11] J. Kantrowitz,et al. Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches , 2020, CNS Drugs.
[12] S. Alcaro,et al. Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates , 2020, Molecules.
[13] Zhilong Chen,et al. Design, synthesis and biological evaluation of novel fluoro-substituted benzimidazole derivatives with anti-hypertension activities. , 2020, Bioorganic chemistry.
[14] Mohammad Rashid. Design, synthesis and ADMET prediction of bis-benzimidazole as anticancer agent. , 2020, Bioorganic chemistry.
[15] S. Srivastava,et al. Repurposing Antipsychotics of the Diphenylbutylpiperidine Class for Cancer Therapy. , 2019, Seminars in cancer biology.
[16] Suraj N. Mali,et al. Synthesis, Antimicrobial Screening and In Silico Appraisal of Iminocarbazole Derivatives , 2019, ChemistrySelect.
[17] Suraj N. Mali,et al. Brønsted Acid Catalyzed Domino Synthesis of Functionalized 4H‐Chromens and Their ADMET, Molecular Docking and Antibacterial Studies , 2019, ChemistrySelect.
[18] Nagaiyan Sekar,et al. Design, synthesis, antimicrobial activity and computational studies of novel azo linked substituted benzimidazole, benzoxazole and benzothiazole derivatives , 2019, Comput. Biol. Chem..
[19] D. Grimm,et al. Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension , 2018, International journal of molecular sciences.
[20] M. Iqbal,et al. Recent advancement of piperidine moiety in treatment of cancer- A review. , 2018, European journal of medicinal chemistry.
[21] S. Begum,et al. ANTIOXIDANT POTENTIAL OF PIPERIDINE CONTAINING COMPOUNDS-A SHORT REVIEW , 2018, Asian Journal of Pharmaceutical and Clinical Research.
[22] Heba A. Hassan,et al. Recent updates of fluoroquinolones as antibacterial agents , 2018, Archiv der Pharmazie.
[23] J. Friedman. Pharmacological interventions for psychosis in Parkinson’s disease patients , 2018, Expert opinion on pharmacotherapy.
[24] A. Elbakry,et al. Pharmaceutical and pharmacokinetic evaluation of novel rectal mucoadhesive hydrogels containing tolmetin sodium , 2017, Journal of Pharmaceutical Investigation.
[25] Ou Sha,et al. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells , 2016, Proceedings of the National Academy of Sciences.
[26] C. Kaiser,et al. New pentasubstituted pyrrole hybrid atorvastatin-quinoline derivatives with antiplasmodial activity. , 2016, Bioorganic & medicinal chemistry letters.
[27] Y. Bansal,et al. The therapeutic journey of benzimidazoles: a review. , 2012, Bioorganic & medicinal chemistry.
[28] S. Arnold,et al. A preclinical view of cholinesterase inhibitors in neuroprotection: do they provide more than symptomatic benefits in Alzheimer's disease? , 2005, Trends in pharmacological sciences.
[29] L. Schneider. Treatment of Alzheimer's disease with cholinesterase inhibitors. , 2001, Clinics in geriatric medicine.
[30] M. Jann,et al. Preclinical Pharmacology of Metrifonate , 1998, Pharmacotherapy.
[31] K. Davis,et al. The search for disease-modifying treatment for Alzheimer's disease , 1997, Neurology.
[32] L A Beckett,et al. Age-specific incidence of Alzheimer's disease in a community population. , 1995, JAMA.
[33] E. Kokmen,et al. The prevalence of dementia is changing over time in Rochester, Minnesota , 1995, Neurology.
[34] R. D'Agostino,et al. Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study , 1992, Neurology.
[35] O. Parsons,et al. Neuropsychology of dementia. , 1986, Neurologic clinics.
[36] R. Terry,et al. Senile dementia of the Alzheimer type , 1983, Annals of neurology.
[37] R. Vardanyan. Classes of Piperidine-Based Drugs , 2018 .
[38] A. Krämer,et al. Small Molecules in Hematology , 2018, Recent Results in Cancer Research.
[39] S. Arnold,et al. Reversible dementias. , 1993, The Medical clinics of North America.